Filtros de búsqueda

Lista de obras de Rossana Berardi

5-Fluorouracil pharmacogenomics: still rocking after all these years?

scientific article published on February 2011

A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy

scientific article published on 25 August 2020

A cost-benefit analysis of chemotherapy for gastric cancer

artículo científico publicado en 2004

A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay

artículo científico publicado en 2017

A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.

artículo científico publicado en 2008

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

artículo científico publicado en 2019

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

scientific article published on 01 June 2019

A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.

artículo científico publicado en 2012

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

scientific article published on 03 January 2012

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

scientific article published on 05 December 2019

Adenocarcinoma arising from ileoanal J-pouch mucosa

artículo científico publicado en 2011

Adjuvant Treatment After Surgical Resection

Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.

artículo científico publicado en 2003

Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients

artículo científico publicado en 2010

An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival

artículo científico publicado en 2020

An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change?

artículo científico publicado en 2010

Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations

artículo científico publicado en 2014

Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer

artículo científico publicado en 2006

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-r

scientific article published on 04 February 2020

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice.

artículo científico publicado en 2006

Are liver nested stromal epithelial tumors always low aggressive?

artículo científico publicado en 2017

Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

artículo científico publicado en 2008

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma

Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors

artículo científico publicado en 2014

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients

artículo científico publicado en 2019

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management

artículo científico publicado en 2020

Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review

artículo científico publicado en 2006

Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients

scientific article published on 11 July 2019

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

artículo científico publicado en 2015

Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options

artículo científico publicado en 2013

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

artículo científico publicado en 2020

COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.

artículo científico publicado en 2007

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

artículo científico publicado en 2020

Can we consider zoledronic acid a new antitumor agent? Recent evidence in clinical setting.

artículo científico publicado en 2010

Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.

artículo científico publicado en 2006

Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial

artículo científico publicado en 2008

Chemotherapy for advanced gastric cancer: across the years for a standard of care

artículo científico publicado en 2007

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

artículo científico publicado en 2020

Chromium exposure and germinal embryonal carcinoma: first two cases and review of the literature.

artículo científico publicado en 2015

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

scientific article published on 22 February 2019

Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma.

artículo científico publicado en 2016

Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy

artículo científico publicado en 2019

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

artículo científico publicado en 2017

Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib

artículo científico publicado en 2014

Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?

artículo científico publicado en 2009

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50

artículo científico publicado en 2020

Compliance with breast and cervical cancer screening programs in women: results from a population-based study

artículo científico publicado en 2013

Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

artículo científico publicado en 2020

Correction to: Expectations and psychological issues before genetic counseling: analysis of distress determinant factors

artículo científico publicado en 2020

Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus.

artículo científico publicado en 2016

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer.

artículo científico publicado en 2010

Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer

artículo científico publicado en 2013

Developments in the management of advanced soft-tissue sarcoma - olaratumab in context

artículo científico publicado en 2018

Differences in terms of progression-free survival (PFS) and overall survival (OS) in patients treated with first-line sorafenib, sunitinib, and pazopanib for late relapsing (>5 years) renal cell carcinoma

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

scientific article published on 05 August 2020

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

scientific article published on 15 November 2019

Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challenges

artículo científico publicado en 2016

Editorial: Emerging Immunotargets in Genitourinary Tumors

artículo científico publicado en 2016

Effective prevention of 5-fluorouracil-induced superficial phlebitis by ketoprofen lysine salt gel.

artículo científico publicado en 2003

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

artículo científico publicado en 2013

Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy.

artículo científico publicado en 2005

Elderly patients with advanced non-small cell lung cancer. A pase II study with weekly cisplatin and gemcitabine

artículo científico publicado en 2003

Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis

artículo científico publicado en 2020

Emerging Immunotargets and Immunotherapies in Prostate Cancer.

artículo científico publicado en 2016

Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.

artículo científico

Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma.

artículo científico publicado en 2014

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis

artículo científico publicado en 2009

Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.

artículo científico publicado en 2007

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

artículo científico publicado en 2004

Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.

artículo científico publicado en 2009

Epidermal growth factor receptor status in stages of resected non-small cell lung cancer: implications for treatment with epidermal growth factor receptor inhibitors

artículo científico publicado en 2011

Epidermal growth factor receptor: a promising therapeutic target for colorectal cancer

artículo científico publicado en 2006

Essential role of Gli proteins in glioblastoma multiforme.

artículo científico

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

artículo científico publicado en 2020

Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options.

artículo científico publicado en 2010

Expectations and psychological issues before genetic counseling: analysis of distress determinant factors

artículo científico publicado en 2020

Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival

scientific article published on 10 September 2019

Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy

artículo científico publicado en 2008

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status

scientific article published on 25 March 2020

Gastric cancer treatment: a systematic review.

artículo científico publicado en 2004

Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach?

artículo científico publicado en 2016

Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy--A literature review

artículo científico publicado en 2015

Gender Differences and Outcomes in Melanoma Patients

scientific article published on 04 February 2020

Gender differences and outcome of melanoma patients.

artículo científico publicado en 2015

Healthcare cost of HER2-positive and negative breast tumors in the United States (2012-2035).

artículo científico

High CTLA-4 expression correlates with poor prognosis in thymoma patients

artículo científico publicado en 2018

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive

artículo científico publicado en 2004

High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients

artículo científico publicado en 2020

Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex ⬇️

artículo científico publicado en 2016

Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma

artículo científico publicado en 2014

Hyponatraemia--SIADH in lung cancer diagnostic and treatment algorithms

artículo científico

Hyponatremia in cancer patients: Time for a new approach.

artículo científico publicado en 2016

Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study

scientific article published on 01 April 2020

Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients.

artículo científico publicado en 2015

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy

artículo científico publicado en 2016

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

artículo científico publicado en 2020

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts.

artículo científico publicado en 2017

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

artículo científico publicado en 2020

Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing

scientific article published on 23 September 2020

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy

artículo científico publicado en 2015

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients

artículo científico publicado en 2017

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms

artículo científico publicado en 2018

In Reply:

In Reply:

Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.

artículo científico publicado en 2017

Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.

artículo científico publicado en 2014

Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.

artículo científico publicado en 2010

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review

scientific article published on 06 January 2020

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

artículo científico publicado en 2020

Locally Advanced Rectal Cancer Patients Receiving Radio-Chemotherapy: A Novel Clinical–Pathologic Score Correlates With Global Outcome

artículo científico publicado en 2009

Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.

scientific article published on October 2009

Locally advanced rectal cancer: the importance of a multidisciplinary approach.

artículo científico publicado en 2014

Long-responders to anti-HER2 therapies: A case report and review of the literature

artículo científico publicado en 2017

Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters

artículo científico publicado en 2015

Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients

artículo científico publicado en 2003

Maspin Staining and Its Use as Biomarker in Lung Cancer

Maspin expression is a favorable prognostic factor in non-small cell lung cancer

scientific article published on 01 April 2012

Medical treatment for gastro-entero-pancreatic neuroendocrine tumours

artículo científico publicado en 2016

Metabolic phenotype of bladder cancer

artículo científico publicado en 2016

Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients

artículo científico publicado en 2006

Modifications of taste sensitivity in cancer patients: a method for the evaluations of dysgeusia

artículo científico publicado en 2019

Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.

artículo científico publicado en 2004

Mucinous Rectal Adenocarcinoma Can Be Associated to Tumor Downstaging after Preoperative Chemoradiotherapy

artículo científico publicado en 2007

Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.

artículo científico publicado en 2009

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

artículo científico publicado en 2012

Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey

artículo científico publicado en 2013

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

artículo científico publicado en 2013

Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives.

artículo científico publicado en 2014

New findings on thymic epithelial tumors: Something is changing.

artículo científico publicado en 2015

New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols

artículo científico publicado en 2005

New target therapies in advanced pancreatic cancer.

artículo científico publicado en 2006

Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma: When is the revolution coming?

artículo científico

Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.

artículo científico publicado en 2010

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.

artículo científico

Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy

article

Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy

artículo científico publicado en 2012

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis

scientific article published on 05 April 2017

Optimal management of resected gastric cancer.

artículo científico publicado en 2018

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis

artículo científico publicado en 2017

Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.

artículo científico publicado en 2005

Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study

artículo científico publicado en 2020

PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

artículo científico publicado en 2015

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

artículo científico publicado en 2018

Pancreatic cancer: progress in cancer therapy.

artículo científico publicado en 2008

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

artículo científico publicado en 2010

Patient and caregiver needs in oncology. An Italian survey.

artículo científico publicado en 2015

Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells

artículo científico publicado en 2013

Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial

artículo científico publicado en 2010

Performance at Preoperative Stair-Climbing Test Is Associated With Prognosis After Pulmonary Resection in Stage I Non-Small Cell Lung Cancer

article published in 2012

Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers

artículo científico publicado en 2005

Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours

artículo científico publicado en 2012

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).

artículo científico publicado en 2006

Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients

artículo científico publicado en 2011

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

artículo científico publicado en 2007

Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer.

artículo científico publicado en 2016

Practical issues for the management of hyponatremia in oncology

artículo científico publicado en 2018

Pre-operative treatment modalities in gastric cancer patients.

artículo científico publicado en 2005

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

artículo científico publicado en 2015

Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

scientific article published on 05 September 2013

Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer

artículo científico publicado en 2019

Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.

artículo científico publicado en 2004

Preoperative maximum oxygen consumption is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer

artículo científico publicado en 2014

Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer

artículo científico publicado en 2012

Present and future of tyrosine kinase inhibitors in renal cell carcinoma: analysis of hematologic toxicity.

artículo científico

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study ⬇️

artículo científico

Primary tumor site (pTS) as a key factor in influencing differential outcome in resected colorectal cancer patients treated with adjuvant XELOX/FOLFOX6

scientific article published on 01 June 2017

Professional failure: how do oncologists feel it?

scientific article published on 29 October 2011

Prognostic Role ofInterleukin-1βGene andInterleukin-1 Receptor AntagonistGene Polymorphisms in Patients With Advanced Gastric Cancer

article

Prognostic factors in early-stage triple-negative breast cancer: lessons and limits from clinical practice

artículo científico publicado en 2013

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors.

artículo científico publicado en 2017

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy

artículo científico publicado en 2016

Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach

artículo científico publicado en 2020

Progress of molecular targeted therapies for advanced renal cell carcinoma.

artículo científico

Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO)

artículo científico publicado en 2020

Prostate cancer: from Gleason scoring to prognostic grade grouping

artículo científico publicado en 2016

Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis

artículo científico publicado en 2020

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

artículo científico publicado en 2007

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

artículo científico publicado en 2012

Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4.

artículo científico publicado en 2016

Resected biliary tract cancers: A novel clinical–pathological score correlates with global outcome

scientific article published on 19 September 2012

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials

artículo científico publicado en 2016

Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials

artículo científico publicado en 2014

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

artículo científico publicado en 2016

Role of DCE-MR in predicting breast cancer subtypes

artículo científico publicado en 2018

Role of maspin in cancer

artículo científico publicado en 2013

Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor.

artículo científico publicado en 2013

SIADH: differential diagnosis and clinical management

artículo científico publicado en 2016

Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic

artículo científico publicado en 2020

Second-line chemotherapy with irinotecan, 5-fluorouracil and leucovorin (FOLFIRI) in relapsed or metastatic gastric cancer: lessons from clinical practice

artículo científico publicado en 2011

Size does matter: Comparison of activity between anti-EGFR and anti-VEGF based-treatments in RAS wild type colorectal cancer patients, stratified by sizes of metastatic involvement

artículo científico publicado en 2017

Somatostatin analogs: is one better than other?

artículo científico publicado en 2017

Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

scientific article published on 02 November 2013

Speckle-tracking global longitudinal strain as an early predictor of cardiotoxicity in breast carcinoma.

artículo científico publicado en 2016

State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors

artículo científico publicado el 1 de febrero de 2011

State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review.

artículo científico

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management

scientific article published on 24 July 2020

Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study

artículo científico publicado en 2019

Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis

scientific article published on 01 July 2018

Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

artículo científico publicado en 2016

Systemic treatment for lung carcinoids: from bench to bedside

scientific article published on 04 July 2019

Testing PD-1/PD-L1 Expression in Cancer Therapy: Pathologic Insights and Economic Sustainability

artículo científico publicado en 2016

The DUR studies: colon cancer adjuvants

artículo científico publicado en 2004

The Italian Rare Pancreatic Exocrine Cancer Initiative

scientific article published on 09 April 2019

The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy

scientific article published on 04 August 2016

The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer

artículo científico publicado en 2020

The origin of prostate metastases: emerging insights.

artículo científico

The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients

artículo científico publicado en 2005

The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.

artículo científico publicado en 2011

The role of an immune checkpoint score in resected non-small cell lung cancer patients' prognosis

artículo científico publicado en 2017

The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis

scientific article published on 21 August 2010

The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.

artículo científico publicado en 2015

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.

artículo científico publicado en 2015

Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review.

artículo científico publicado en 2013

Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives.

artículo científico publicado en 2009

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

artículo científico publicado en 2010

Treatment trends in metastatic pancreatic cancer patients: Is it time to change?

article published in 2011

TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study

artículo científico publicado en 2021

Trifluridine tipiracil (TAS 102) in patients with stage IV pretreated colorectal neoplasm: an experience from Rimini City Hospital

scientific article published on 01 June 2017

Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients

artículo científico publicado en 2007

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities

artículo científico publicado en 2016

Women and lung cancer: clinical and molecular profiling as a determinate for treatment decisions: a literature review.

artículo científico publicado en 2008

Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: a new strategy to improve immunotherapy efficacy?

artículo científico publicado en 2017

[ (11) C]-methionine positron emission tomography in the postoperative imaging and followup of patients with primary and recurrent gliomas.

artículo científico publicado en 2014

[Non-small cell lung carcinoma: pathology, biology and prognosis]

scientific article published on 01 March 2004

“Biliary tract cancers: Molecular profiling as a tool for treatment decisions. A literature review” [Cancer Treatment Reviews 32(5) (2006) 333–347]

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda